We are live on ! Find out more
VIVO

Meridian Bioscience Inc
VIVO

Delisted

VIVO was delisted on the 30th of January, 2023.

Back to rankings

177 hedge funds and large institutions have $615M invested in Meridian Bioscience Inc in 2018 Q2 according to their latest regulatory filings, with 16 funds opening new positions, 69 increasing their positions, 49 reducing their positions, and 22 closing their positions.

New
Increased
Maintained
Reduced
Closed

657% more call options, than puts

Call options by funds: $2.13M | Put options by funds: $281K

41% more repeat investments, than reductions

Existing positions increased: 69 | Existing positions reduced: 49

14% more capital invested

Capital invested by funds: $541M → $615M (+$74.1M)

5% less funds holding

Funds holding: 186 → 177 (-9)

27% less first-time investments, than exits

New positions opened: 16 | Existing positions closed: 22

Holders
177
Holders Change
-9
Holders Change %
-4.84%
% of All Funds
4.05%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
16
Increased
69
Reduced
49
Closed
22
Calls
$2.13M
Puts
$281K
Net Calls
+$1.85M
Net Calls Change
+$1.38M

Top Buyers

Rank Fund Capital Flow
1
BlackRock
BlackRock
New York
+$7.74M
2
Citadel Advisors
Citadel Advisors
Florida
+$4.05M
3
Renaissance Technologies
Renaissance Technologies
New York
+$3.29M
4
SBH
Segall Bryant & Hamill
Illinois
+$3.16M
5
Invesco
Invesco
Georgia
+$2.26M

Top Sellers

Rank Fund Capital Flow
1
Millennium Management
Millennium Management
New York
-$5.9M
2
BCM
Brown Capital Management
Maryland
-$5.14M
3
Rafferty Asset Management
Rafferty Asset Management
New York
-$4.43M
4
New York State Common Retirement Fund
New York State Common Retirement Fund
New York
-$3.25M
5
Prudential Financial
Prudential Financial
New Jersey
-$2.14M
Name Holding Trade Value Shares
Change 		Change in
Stake
Man Group
26
Man Group
United Kingdom
$4.48M +$475K +31,830 +13%
D.E. Shaw & Co
27
D.E. Shaw & Co
New York
$4.46M +$1.21M +80,960 +41%
MAM
28
Martingale Asset Management
Massachusetts
$4.28M +$17.9K +1,200 +0.4%
Goldman Sachs
29
Goldman Sachs
New York
$4.12M +$940K +63,024 +32%
Two Sigma Advisers
30
Two Sigma Advisers
New York
$4.12M +$476K +31,900 +14%
Prudential Financial
31
Prudential Financial
New Jersey
$3.9M -$2.14M -143,646 -37%
SBH
32
Segall Bryant & Hamill
Illinois
$3.37M +$3.16M +211,886 New
GF
33
Gabelli Funds
New York
$3.12M -$119K -8,000 -4%
SCA
34
Secor Capital Advisors
New York
$2.85M +$250K +16,727 +10%
CIS
35
Connors Investor Services
Pennsylvania
$2.85M -$122K -8,182 -4%
GI
36
GAMCO Investors
Connecticut
$2.73M -$44.7K -3,000 -2%
OAM
37
Oxford Asset Management
United Kingdom
$2.73M +$420K +28,125 +20%
Hotchkis & Wiley Capital Management
38
Hotchkis & Wiley Capital Management
California
$2.7M +$2.13M +142,867 +525%
LSV Asset Management
39
LSV Asset Management
Illinois
$2.61M – – –
TA
40
Teton Advisors
New York
$2.46M – – –
MIP
41
Mondrian Investment Partners
United Kingdom
$2.39M -$10.6K -713 -0.5%
Barrow, Hanley, Mewhinney & Strauss
42
Barrow, Hanley, Mewhinney & Strauss
Texas
$2.37M – – –
SIM
43
Spark Investment Management
New York
$2.35M – – –
RA
44
Royce & Associates
New York
$2.34M +$6.68K +448 +0.3%
CS
45
Credit Suisse
Switzerland
$2.27M -$112K -7,528 -5%
GCP
46
GSA Capital Partners
United Kingdom
$2.22M -$268K -17,941 -11%
Two Sigma Investments
47
Two Sigma Investments
New York
$2.2M +$1.09M +73,060 +112%
New York State Teachers Retirement System (NYSTRS)
48
New York State Teachers Retirement System (NYSTRS)
New York
$2.12M -$51K -3,422 -3%
Fifth Third Bancorp
49
Fifth Third Bancorp
Ohio
$2.02M -$740K -49,640 -28%
PNC Financial Services Group
50
PNC Financial Services Group
Pennsylvania
$1.84M -$567 -38 -0%
1
2
3 4 5

VIVO Hedge Fund Activity: Q2 2018 in Review

177 of the 4,368 institutional investors tracked by Wall St. Rank reported a position in Meridian Bioscience Inc (VIVO) for Q2 2018, worth a combined $615M — up 14% from $541M a quarter earlier.

Sellers outnumbered buyers: 22 funds closed out of VIVO and 16 opened new positions — a net loss of 6 holders — while 49 trimmed existing stakes and 69 added.

The largest buyer was BlackRock, adding an estimated $7.74M. The largest seller was Millennium Management, cutting an estimated $5.9M.

  • 177 institutional investors held Meridian Bioscience Inc (VIVO) as of Q2 2018, down from 186 in Q1 2018.
  • Funds reported $615M of Meridian Bioscience Inc stock for Q2 2018, up 14% quarter-over-quarter.
  • 16 funds opened new Meridian Bioscience Inc positions in Q2 2018 and 22 closed out, a net change of -6 holders.
  • The largest Meridian Bioscience Inc buyer in Q2 2018 was BlackRock, an estimated $7.74M added.
  • The largest Meridian Bioscience Inc seller in Q2 2018 was Millennium Management, an estimated $5.9M sold.

Based on aggregated 13F filings for Q2 2018.